Barbara Klencke, CMO at Sierra Oncology, holds 0.00 shares in Sierra Oncology (Ticker: SRRA), holds ― shares in eFFECTOR Therapeutics (Ticker: EFTR), holds 70.00K shares in TScan Therapeutics (Ticker: TCRX).
What is the percentage of profitable transactions made by Barbara Klencke?
The percentage of profitable transactions made by Barbara Klencke is 80%.
What is the average return per transaction made by Barbara Klencke?
The average return per transaction made by Barbara Klencke is 13.60%.
What stocks does Barbara Klencke hold?
Barbara Klencke holds: SRRA, EFTR, TCRX, XNCR stocks.
What was Barbara Klencke’s latest transaction?
Barbara Klencke latest transaction was an Uninformative Sell of $825.00K.
What was Barbara Klencke's most profitable transaction?
Barbara Klencke’s most profitable transaction was an Informative Buy of SRRA stock on August 18, 2020. The return on the trade was 53.00%.
What is Barbara Klencke's role in Sierra Oncology?
Barbara Klencke's role in Sierra Oncology is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.